Search Results
Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, China
Search for other papers by Jinrong Fu in
Google Scholar
PubMed
Search for other papers by Zihao Fan in
Google Scholar
PubMed
Search for other papers by Liang He in
Google Scholar
PubMed
Search for other papers by Qian Liu in
Google Scholar
PubMed
Search for other papers by He Liu in
Google Scholar
PubMed
Search for other papers by Yushu Li in
Google Scholar
PubMed
Search for other papers by Haixia Guan in
Google Scholar
PubMed
, including the accessibility of eligible participants during the study period and the feasibility of collecting data. Patients with elevated serum thyroid autoantibodies (thyroid peroxidase antibodies (TPOAb) >200 IU/mL and/or anti-thyroglobulin antibodies
INSERM 1086 ANTICIPE, Caen University, Caen, France
Search for other papers by Renaud Ciappuccini in
Google Scholar
PubMed
Search for other papers by Virginie Saguet-Rysanek in
Google Scholar
PubMed
Search for other papers by Marine Dorbeau in
Google Scholar
PubMed
Search for other papers by Justine Lequesne in
Google Scholar
PubMed
Search for other papers by Camille Linard in
Google Scholar
PubMed
Search for other papers by Sophie Lefevre-Arbogast in
Google Scholar
PubMed
Search for other papers by Bénédicte Clarisse in
Google Scholar
PubMed
Search for other papers by Stéphane Bardet in
Google Scholar
PubMed
thyroid gland was assessed by measuring SUVmax, SUVmax EARL , and SUVmean. Laboratory data Serum for thyrotropin (TSH), free thyroxine (FT4), thyroid peroxidase antibodies (TPOAb), and thyroglobulin antibodies (TgAb) were collected for measurements
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
National Board of Health, Nuuk, Greenland
Search for other papers by Paneeraq Noahsen in
Google Scholar
PubMed
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
Department of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland
Search for other papers by Karsten F Rex in
Google Scholar
PubMed
Search for other papers by Inge Bülow Pedersen in
Google Scholar
PubMed
Queen Ingrid’s Health Care Centre, Nuuk, Greenland
Search for other papers by Gert Mulvad in
Google Scholar
PubMed
Search for other papers by Hans Christian Florian-Sørensen in
Google Scholar
PubMed
Search for other papers by Michael Lynge Pedersen in
Google Scholar
PubMed
Ilisimatusarfik, University of Greenland, Nuuk, Greenland
Department of Internal Medicine, Queen Ingrid’s Hospital, Nuuk, Greenland
Department of Geriatric Medicine, Aalborg University Hospital, Aalborg, Denmark
Search for other papers by Stig Andersen in
Google Scholar
PubMed
Medical Sciences 1967 32 70 – 82 . 12 Laurberg P Thyroxine and 3,5,3-triiodothyronine content of thyroglobulin in thyroid needle aspirates in hyperthyroidism and hypothyroidism . Journal of Clinical Endocrinology and Metabolism 1987 64 969 – 974
Search for other papers by Liyuan Liu in
Google Scholar
PubMed
Search for other papers by Yang Yu in
Google Scholar
PubMed
Search for other papers by Lei Chen in
Google Scholar
PubMed
Search for other papers by Yang Zhang in
Google Scholar
PubMed
Search for other papers by Guizhi Lu in
Google Scholar
PubMed
Search for other papers by Ying Gao in
Google Scholar
PubMed
Search for other papers by Junqing Zhang in
Google Scholar
PubMed
peroxidase and thyroglobulin) ( 1 ). In 2009, Li et al. ( 2 ) first proposed dividing HT into IgG4 and non-IgG4 HT based on IgG4 and IgG immunohistochemical staining results in thyroid tissue and found that IgG4 HT had unique clinical, serological
Search for other papers by Joanna Bogusławska in
Google Scholar
PubMed
Search for other papers by Marlena Godlewska in
Google Scholar
PubMed
Search for other papers by Ewa Gajda in
Google Scholar
PubMed
Search for other papers by Agnieszka Piekiełko-Witkowska in
Google Scholar
PubMed
(TPO) catalyzes iodination of tyrosines in thyroglobulin (Tg), which attaches one or two iodine to form monoiodotyrosine (MIT) or diiodotyrosine (DIT), respectively. TPO also catalyzes the coupling of iodotyrosine residues to form triiodothyronine (T3
Search for other papers by Hsu-Hua Tseng in
Google Scholar
PubMed
Search for other papers by Yen-Bo Lin in
Google Scholar
PubMed
Search for other papers by Kuan-Yu Lin in
Google Scholar
PubMed
Search for other papers by Chia-Hung Lin in
Google Scholar
PubMed
Search for other papers by Hung-Yuan Li in
Google Scholar
PubMed
Search for other papers by Chia-Hsuin Chang in
Google Scholar
PubMed
Search for other papers by Yi-Ching Tung in
Google Scholar
PubMed
Graduate Institute of Medical Genomics and Proteomics, National Taiwan University College of Medicine, Taipei, Taiwan
Department of Medical Genetics, National Taiwan University Hospital, Taipei, Taiwan
Search for other papers by Pei-Lung Chen in
Google Scholar
PubMed
Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
Search for other papers by Chih-Yuan Wang in
Google Scholar
PubMed
Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
Search for other papers by Wei-Shiung Yang in
Google Scholar
PubMed
Department of Internal Medicine, National Taiwan University College of Medicine, Taipei, Taiwan
Center of Anti-Aging and Health Consultation, National Taiwan University Hospital, Taipei, Taiwan
Search for other papers by Shyang-Rong Shih in
Google Scholar
PubMed
Diagnostics), anti-thyroglobulin antibody (anti-Tg Ab, reference range: <14.3 IU/mL, Abbott Architect i2000SR using reagents provided by Abbott Diagnostics), and thyrotropin-binding inhibitory immunoglobulin (TBII, reference range: < 10%, R.S.R. Ltd. Cardiff
Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Porto, Portugal
Search for other papers by Liliana Ribeiro Santos in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Search for other papers by Inês Vasconcelos Bessa in
Google Scholar
PubMed
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Public Health Unit, ACES Baixo Mondego, Coimbra, Portugal
Search for other papers by Adriana Gaspar da Rocha in
Google Scholar
PubMed
Department of Endocrinology, Hospital University Centre of São João, Porto, Portugal
Search for other papers by Celestino Neves in
Google Scholar
PubMed
Search for other papers by Cláudia Freitas in
Google Scholar
PubMed
Faculty of Medicine of the University of Porto (FMUP), Porto, Portugal
Health Investigation and Innovation Institute (i3S), University of Porto, Porto, Portugal
Department of Pathology, Faculty of Medicine of the University of Porto, Porto, Portugal
Search for other papers by Paula Soares in
Google Scholar
PubMed
disease; FT3, free triiodothyronine; FT4, free thyroxine; GD, Graves' disease; GO, Graves' ophthalmopathy; HT, Hashimoto thyroiditis; IL-2 /TNF-α, proinflammatory cytokines; Se-Su, selenium supplementation; TGAb, thyroglobulin antibody; TPOAb, thyroid
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Liyun Shen in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Lei Ye in
Google Scholar
PubMed
Search for other papers by Wei Zhu in
Google Scholar
PubMed
Search for other papers by Qin Jiao in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Yulin Zhou in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Shu Wang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Weiqing Wang in
Google Scholar
PubMed
Shanghai National Clinical Research Center for Metabolic Diseases, Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Search for other papers by Guang Ning in
Google Scholar
PubMed
thyroxine, thyroid-stimulating hormone (TSH), TSH receptor autoantibodies (TRAb), thyroid peroxidase antibody, and thyroglobulin antibody are shown as median and quartiles of the original values and log10 normal transformed before statistical analysis. For